Next Article in Journal
Next Article in Special Issue
Previous Article in Journal
Previous Article in Special Issue
Biomolecules 2013, 3(2), 316-333; doi:10.3390/biom3020316
Article

The Roles of Sphingosine Kinase 1 and 2 in Regulating the Metabolome and Survival of Prostate Cancer Cells

1
, 1
, 2,3
, 3
, 3
, 4
, 1
, 1
 and 1,*
Received: 9 May 2013; in revised form: 3 June 2013 / Accepted: 4 June 2013 / Published: 10 June 2013
(This article belongs to the Special Issue Sphingolipids and Bioactive Lipids)
View Full-Text   |   Download PDF [343 KB, uploaded 10 June 2013]   |   Browse Figures
Abstract: We have previously shown that treatment of androgen-sensitive LNCaP cells with the sphingosine kinase (SK) inhibitor SKi (2-(p-hydroxyanilino)-4-(p-chlorophenyl)thiazole) induces the proteasomal degradation of two N-terminal variants of SK1 (SK1a and SK1b), increases C22:0-ceramide and diadenosine 5′,5′′′-P1,P3-triphosphate (Ap3A) and reduces S1P levels, and promotes apoptosis. We have now investigated the effects of three SK inhibitors (SKi, (S)-FTY720 vinylphosphonate, and (R)-FTY720 methyl ether) on metabolite and sphingolipid levels in androgen-sensitive LNCaP and androgen-independent LNCaP-AI prostate cancer cells. The 51 kDa N-terminal variant of SK1 (SK1b) evades the proteasome in LNCaP-AI cells, and these cells do not exhibit an increase in C22:0-ceramide or Ap3A levels and do not undergo apoptosis in response to SKi. In contrast, the SK inhibitor (S)-FTY720 vinylphosphonate induces degradation of SK1b in LNCaP-AI, but not in LNCaP cells. In LNCaP-AI cells, (S)-FTY720 vinylphosphonate induces a small increase in C16:0-ceramide levels and cleavage of polyADPribose polymerase (indicative of apoptosis). Surprisingly, the level of S1P is increased by 7.8- and 12.8-fold in LNCaP and LNCaP-AI cells, respectively, on treatment with (S)-FTY720 vinylphosphonate. Finally, treatment of androgen-sensitive LNCaP cells with the SK2-selective inhibitor (R)-FTY720 methyl ether increases lysophosphatidylinositol levels, suggesting that SK2 may regulate lyso-PI metabolism in prostate cancer cells.
Keywords: Sphingosine kinase inhibitors; lyso-phosphatidylinositol; sphingolipids; diadenosine 5′,5′′′-P1,P3-triphosphate Sphingosine kinase inhibitors; lyso-phosphatidylinositol; sphingolipids; diadenosine 5′,5′′′-P1,P3-triphosphate
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Tonelli, F.; Alossaimi, M.; Natarajan, V.; Gorshkova, I.; Berdyshev, E.; Bittman, R.; Watson, D.G.; Pyne, S.; Pyne, N.J. The Roles of Sphingosine Kinase 1 and 2 in Regulating the Metabolome and Survival of Prostate Cancer Cells. Biomolecules 2013, 3, 316-333.

AMA Style

Tonelli F, Alossaimi M, Natarajan V, Gorshkova I, Berdyshev E, Bittman R, Watson DG, Pyne S, Pyne NJ. The Roles of Sphingosine Kinase 1 and 2 in Regulating the Metabolome and Survival of Prostate Cancer Cells. Biomolecules. 2013; 3(2):316-333.

Chicago/Turabian Style

Tonelli, Francesca; Alossaimi, Manal; Natarajan, Viswanathan; Gorshkova, Irina; Berdyshev, Evgeny; Bittman, Robert; Watson, David G.; Pyne, Susan; Pyne, Nigel J. 2013. "The Roles of Sphingosine Kinase 1 and 2 in Regulating the Metabolome and Survival of Prostate Cancer Cells." Biomolecules 3, no. 2: 316-333.



Biomolecules EISSN 2218-273X Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert